While we all know that COVID-19 has promoted growth in the vaccine contract manufacturing market, what other factors are impacting the field? In this article, EPR summarises the trends and opportunities identified by a new market research report.
According to a new market research report, the global vaccine contract manufacturing market is anticipated to value $4 billion by 2026, expanding at a compound annual growth rate (CAGR) of 13 percent between 2021 and 2026.
This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.
Key learning points:
Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
Learn about ITM’s implementation journey and considerations when evaluating the technology
Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).
Don’t miss your chance to learn from experts in the industry –Register for FREE
Can’t attend live? No worries – register to receive the recording post-event.
The report explains the significant impact that the COVID-19 pandemic has had on vaccine development and thus this market. According to the report, the new era of vaccine and biological drug development brought on by the pandemic has resulted in radical transformations in the vaccine contract manufacturing market. One change is the focus on RNA-based COVID vaccines, a novel concept rapidly accelerated by the pandemic, which contract manufacturing companies are still working to increase the availability of.
According to the report, to meet the demands of the pandemic, almost three quarters of the pharma and biotech companies have entered into mergers and agreements with contract manufacturers to develop COVID-19 vaccines. The analysts suggest this is because outsourcing has numerous benefits to manufacturing in-house, including end-to-end manufacturing solutions and expertise in vaccine manufacturing.
Other factors that may encourage growth in the market include growing populations and healthcare awareness, demand for newer vaccination products, increasing global vaccination coverage.
Market by scale of operation
According to the report, commercial vaccine contract manufacturing accounted for over 64 percent of the market in 2020, primarily as a result of the COVID-19 pandemic.
The clinical vaccine contract manufacturing market is expected to experience an absolute growth of over 113 percent and an incremental growth of over $492 million over the forecast period. The authors of the report suggest that recent pandemics and epidemics, including COVID-19, Ebola and Lassa fever have all highlighted the urgent need for vaccines and therapeutics against emerging and re-emerging infectious diseases. As a result, the preclinical segment accounted for a share of 13 percent of the global vaccine contract manufacturing market in 2020 and there are now several serums in the pipeline for wide-ranging contagious diseases, including COVID-19.
Contract manufacturing by vaccine type
Sub-unit vaccines accounted for the largest share of the market in 2020, some 34 percent, and are likely to witness the highest incremental growth (over $633 million) during the forecast period. The report states that this is due to the emergence of pandemics and epidemics forcing national and international bodies to implement stricter vaccination programmes, which is likely to increase the demand for vaccine production and thus drive growth in the vaccine contract manufacturing market.
The global live-attenuated vaccines contract manufacturing market is anticipated to grow to over $1 billion by 2026, since live attenuated serums are one of the most widely used vaccination technologies. They have complex manufacturing requirements, which increase pharma and biotech R&D budgets and thus companies outsource their manufacture to meet demands and reduce costs.
Interestingly, the report states that RNA vaccines are faster and less expensive than traditional ones. With the mRNA platform positioned as the emerging, non-infectious and non-integrating technology and the global RNA market expected to observe an incremental growth of over 124 percent during the forecast period, how this will affect contract manufacturing is undecided.
By service
The fill/finish services market is anticipated to grow at a CAGR of approximately 13 percent between 2020 and 2026. According to the report, these steps are often outsourced because of the extreme regulatory scrutiny in this area – and because fill/finish tend to be costly. Hence, vaccine manufacturers outsource these services to CMOs. Additionally, biopharma companies outsource fill/finish needs to gain access to specialised technology.
The report also states that the analytical and QC studies services market is expected to observe an incremental growth of over $322 million by 2026. An increase in product-pipeline manufacturing requiring both method development and method validation is apparently driving several biopharma companies to opt for analytical method development services.
By geography
North America has a high number of CMOs and accounted for the largest share of the vaccine contract manufacturing marker (35 percent) in 2020. Within the region, the US holds over 90 percent of the market and Canada approximately 10 percent. According to the report, the trend of outsourcing is being supported by manufacturing regulations in the region, as well as the demand for vaccines to treat the increasing number of deaths caused by vaccine-preventable diseases.
Europe has the second highest share of the vaccine contract manufacturing market in 2020 at 26 percent. According to the authors, the increasing elderly population, prevalence of bacterial and viral infections, increasing demand of new vaccinations and expanding biopharma and biotech industry are major factors contributing to the growth of contract manufacturing in Europe. This region has few prominent vaccine contract manufacturing players, instead having several small and mid-sized vendors.
The Asia Pacific region (APAC), similar to above, is primarily dominated by small and mid-sized vendors. It is anticipated to witness the largest CAGR, due to the large and growing population high prevalence of infectious diseases and thus high demand for vaccine programmes. According to the report, the growing vaccine pipeline, rise in outsourcing of vaccine manufacturing services and implementation of novel and innovative technologies are all expected to have a significant influence on the vaccine contract manufacturing market in this region.
The report also stated that emerging economies, including China, India, Brazil and Mexico, are likely to offer significant growth opportunities for vendors. The vaccine contract manufacturing market in India is expected to grow at a CAGR of over 15 percent between 2020 and 2026.
Key players
Key players in the vaccine contract manufacturing market market include Ajinomoto BioPharma, Albany Molecular Research Institute, Catalent, Cytovance Biologics, Emergent Biosolutions, Fujifilm Diosynth Biotechnologies and GlaxoSmithKline, among others.
Established players are entering into strategic alliances and co-marketing agreements to elevate the market competitiveness and penetration. They also make long-term relationships with distributors and suppliers for scale-up production and expand geographical presence in the market.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.